X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS CIPLA DR. DATSONS LABS/
CIPLA
 
P/E (TTM) x -10.9 44.6 - View Chart
P/BV x 0.2 3.9 4.2% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 DR. DATSONS LABS   CIPLA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
CIPLA
Mar-17
DR. DATSONS LABS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs126622 20.2%   
Low Rs31458 6.7%   
Sales per share (Unadj.) Rs133.0181.9 73.1%  
Earnings per share (Unadj.) Rs0.212.9 1.2%  
Cash flow per share (Unadj.) Rs6.629.3 22.5%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.8155.7 82.7%  
Shares outstanding (eoy) m31.66804.51 3.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.63.0 19.8%   
Avg P/E ratio x516.142.0 1,229.9%  
P/CF ratio (eoy) x11.818.4 64.3%  
Price / Book Value ratio x0.63.5 17.5%  
Dividend payout %015.5 0.0%   
Avg Mkt Cap Rs m2,477434,516 0.6%   
No. of employees `000NA23.0 0.0%   
Total wages/salary Rs m5626,338 0.2%   
Avg. sales/employee Rs ThNM6,349.1-  
Avg. wages/employee Rs ThNM1,143.0-  
Avg. net profit/employee Rs ThNM449.3-  
INCOME DATA
Net Sales Rs m4,211146,302 2.9%  
Other income Rs m792,287 3.4%   
Total revenues Rs m4,289148,589 2.9%   
Gross profit Rs m56924,758 2.3%  
Depreciation Rs m20413,229 1.5%   
Interest Rs m4301,594 27.0%   
Profit before tax Rs m1312,222 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-70 2.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,798 0.3%   
Profit after tax Rs m510,354 0.0%  
Gross profit margin %13.516.9 79.8%  
Effective tax rate %48.014.7 326.6%   
Net profit margin %0.17.1 1.6%  
BALANCE SHEET DATA
Current assets Rs m6,85287,370 7.8%   
Current liabilities Rs m6,71133,081 20.3%   
Net working cap to sales %3.337.1 9.0%  
Current ratio x1.02.6 38.7%  
Inventory Days Days16187 185.0%  
Debtors Days Days31862 511.1%  
Net fixed assets Rs m3,673111,567 3.3%   
Share capital Rs m3171,609 19.7%   
"Free" reserves Rs m3,761123,645 3.0%   
Net worth Rs m4,078125,254 3.3%   
Long term debt Rs m1,67136,454 4.6%   
Total assets Rs m12,633209,532 6.0%  
Interest coverage x1.08.7 11.9%   
Debt to equity ratio x0.40.3 140.8%  
Sales to assets ratio x0.30.7 47.7%   
Return on assets %3.45.7 60.4%  
Return on equity %0.18.3 1.4%  
Return on capital %7.78.5 90.3%  
Exports to sales %22.934.2 66.9%   
Imports to sales %14.38.3 171.4%   
Exports (fob) Rs m96450,050 1.9%   
Imports (cif) Rs m60212,203 4.9%   
Fx inflow Rs m96451,066 1.9%   
Fx outflow Rs m60717,678 3.4%   
Net fx Rs m35733,388 1.1%   
CASH FLOW
From Operations Rs m1,34523,824 5.6%  
From Investments Rs m-2,256-13,127 17.2%  
From Financial Activity Rs m-1,200-13,239 9.1%  
Net Cashflow Rs m-2,111-2,478 85.2%  

Share Holding

Indian Promoters % 4.5 16.0 28.3%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 0.0 12.2 -  
FIIs % 1.4 23.7 5.7%  
ADR/GDR % 0.0 1.1 -  
Free float % 94.1 26.2 359.2%  
Shareholders   20,807 161,166 12.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Rising Stock Markets, Reduction in Government's Additional Borrowing, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a strong note yesterday. At the closing bell yesterday, the BSE Sensex crossed its 35,000 mark for the first time and stood higher by 311 points (up 0.9%).

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - PIRAMAL ENTERPRISES COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS